Publication details
Differences of biologics to treat psoriasis
| Authors | |
|---|---|
| Year of publication | 2011 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Because of chronic nature of psoriasis we are usually dealing with long-time treatment. So we need to review the safety and efficacy of these agents over longer period including studies of high level of evidence. The possibility to treat with biologics represents great help in elimination of chronic inflammatory status and comorbidities linked to this inflammation. We can control the disease and simultaneously to prevent such risks. |